24, 2025 — A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical ...

Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

The best protein shakers are a must-buy, so we've tried and tested the best on the market to help you decide what to carry before, during and after your workouts. And we've done that much testing ...

The hepatitis B vaccine is a shot, typically injected into the arm, that protects against hepatitis B in babies, children, and adults. It is an important way to protect yourself and your children from ...

shares of this vaccine maker have returned +3.5%, compared to the Zacks S&P 500 composite's +2.1% change. During this period, the Zacks Medical - Biomedical and Genetics industry, which Novavax ...

In this article, we are going to take a look at where Novavax ... of innovative vaccines to prevent serious infectious diseases. The company uses proprietary protein and nanoparticle technologies ...

F protein-subunit based vaccines, adjuvants & potency Both prefusion ... antibody levels and to elicit a Th1 immune response. Novavax is testing a postfusion F protein vaccine formulated with ...

Jan 18 (Reuters) - Robert F. Kennedy Jr. played an instrumental role in organizing mass litigation against drugmaker Merck over its Gardasil vaccine, a strategy that faces its first test in a Los ...

LA JOLLA, CA—Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will produce long-lasting antibodies recognizing that specific ...

"Today, we announce the beginning of an exciting new chapter for Novavax with the launch of a strategically important partnership with one of the world's leading vaccine companies," NVAX CEO John ...